Real-world evidence to be presented at the American College of Cardiology Scientific Session 2026 highlights impact of Viz HCM, developed as part of a multi-year agreement with Bristol Myers Squibb, ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, Inc., a leading AI-driven health technology company and portfolio company of nference, announced today it has received the 2024 MedTech Breakthrough Award ...

The announcement outlines a strategic collaboration between HeartBeam and Mount Sinai to develop and validate high value, ...

Clinicians rely daily on electrocardiograms (ECG) to detect common cardiovascular conditions, but accurate diagnoses require high levels of expertise. In a new study that reviewed nearly 1 million ...

Artificial intelligence (AI)-based ECG interpretation outperformed standard pathways for the detection of occlusive ...

A new clinical study shows that PulseAI’s deep learning AI demonstrates superiority over the Apple Watch ECG in the detection of atrial fibrillation. Results have been accepted for presentation at the ...

A new algorithm developed by researchers at the Mayo Clinic can effectively detect patients with a dangerous heart dysfunction using data gathered by an Apple Watch. A large trial is now underway ...

An artificial intelligence (AI)-based method for interpreting ECGs performed better than standard approaches in detecting ...

Poland-based health tech AI startup Cardiomatics has announced a $3.2 million seed raise to expand use of its electrocardiogram (ECG) reading automation technology. The round is led by Central and ...

Anumana’s innovative AI algorithms recognized for their transformative potential in cardiology - the first of which is now commercially available “At Anumana, we are committed to developing ...

HeartBeam (NASDAQ: BEAT) recently announced a collaboration with Mount Sinai aimed at advancing artificial ...